Enquirer Consulting Group
Hassan Fathallah-Shaykh | MRIMath | October 2026
As of 16 Oct 2026
MRIMath sells an FDA-cleared cyber device and AI for glioblastoma care: AI segmentation, volumetric tracking, a DICOM viewer, a shared cloud teamspace and secure image exchange, offered to clinics and hospitals, to researchers and to patients.
This page maps the organizations whose teams contour, measure and track brain tumors, grouped by type and size, and who usually signs off at each.
Groups with a clean public code are counted and banded. The rest have no clean public count and are listed so the map stays complete.
| Group | Organizations in the US | Under 20 staff | 20 to 99 | 100 to 499 | 500 or more |
|---|---|---|---|---|---|
| General medical and surgical hospitals with radiology and radiation oncology departments | about 2,600 | not published | not published | not published | not published |
| Specialty hospitals, including cancer hospitals | about 330 | not published | not published | not published | not published |
| Diagnostic imaging centers | about 4,700 | about 3,800 | about 490 | about 160 | about 210 |
| Radiation oncology and neuro-oncology physician practices | no clean public count | ||||
| Academic medical centers and university brain tumor research groups | no clean public count | ||||
| Biotechnology research and development firms | about 4,900 | about 4,000 | about 600 | about 240 | about 130 |
US firm counts by industry code, banded deliberately.
Titles vary by organization. The first column is the person who most often owns the decision; the second is who is usually in the room.
| Group | Usually signs off | Also at the table |
|---|---|---|
| General hospitals | Chair of Radiation Oncology or Chair of Radiology | Chief Medical Information Officer, imaging informatics lead, information security, value analysis committee |
| Specialty and cancer hospitals | Medical Director of Radiation Oncology | Chief of Neuro-Oncology, chief medical physicist, dosimetry lead |
| Diagnostic imaging centers | Medical Director | Practice administrator or chief executive, lead neuroradiologist |
| Radiation oncology and neuro-oncology practices | Managing physician | Practice administrator, chief medical physicist |
| Academic medical centers and research groups | Principal investigator or research imaging core director | Department chair, research compliance and data security |
| Biotechnology research firms | Head of clinical imaging or translational imaging | Clinical development lead, clinical operations |
Radiation oncology teams buy time back on contouring. The site describes one-click AI contours for glioblastoma, smart manual segmentation with low inter-user variability, and export in RT-DICOM for radiotherapy planning.
Neuro-oncology and radiology teams buy a consistent read of tumor change. The site describes volumetric measurements and plots that compare pre- and post-treatment volume and track change over time.
Research groups buy clean, shareable data. The site describes anonymization, AI registration across MR and CT, NIfTI export for analysis, and a teamspace for multi-institutional teams.
Every group with patient data asks about security first. The site describes a cyber device with role-based access, encryption and anonymized DICOM handling, and the home page notes its ISO certification for medical device quality.
The MRIMath home, Solutions and Products pages, read 16 October 2026.
In hospitals, a clinical champion in radiation oncology or neuro-oncology brings the tool in, imaging informatics and information security review the cloud and data flow, and a value analysis or capital committee approves the spend.
In practices and imaging centers, the managing physician or medical director decides with the administrator, and the path from demo to decision is shorter.
In research settings, the principal investigator usually holds the budget through a grant or core facility, with compliance signing off on data sharing.
The people who usually sign at the groups above, one a company. Work emails and phone numbers checked on Oct 16, 2026.
| Name | Role | Company | Where | Phone | |
|---|---|---|---|---|---|
| Nikhil Thaker | Medical Director and Chair of Radiation Oncology | Capital Health (US) | Pennington, NJ | nthaker@capitalhealth.org | +1 856 392 4727 |
| C-M Charlie Ma | Professor & Director of Rad Phys, Vice Chair of Radiation Oncology Dept | Fox Chase Cancer Center | Philadelphia, PA | +1 215 728 2996 | |
| Sean O. Perkins MHA R.T. | Director of Radiation Oncology | New Mexico Cancer Center- New Mexico Oncology Hematology Consultants, LTD | Albuquerque-Santa Fe | +1 615 278 6124 | |
| Suzie Bash | Medical Director of Neuroradiology | RadNet | Los Angeles, CA | +1 310 613 1617 | |
| Eric Greif | Director of Neuroradiology | Radiology Partners | Huntington, NY | eric.greif@radpartners.com | +1 917 848 0634 |
| Donald Larsen Jr | Chair of Radiology | Los Angeles General Medical Center | Los Angeles, CA | +1 801 360 4178 | |
| Adam Nevitt | Chair of Radiology and Diagnostic Imaging. | MarinHealth | San Francisco | adam.nevitt@mymarinhealth.org | +1 415 385 1997 |
| Jenny Hoang | Interim Chair of Radiology | The Johns Hopkins University School of Medicine | Baltimore, MD | +1 919 308 0078 | |
| Nam Nguyen | Professor and Chair, Radiation Oncology | Howard University | Washington, DC | nam.nguyen@howard.edu | +1 417 894 2349 |
| Adam Dicker | Professor and Chair, Dept. of Radiation Oncology | Thomas Jefferson University | Philadelphia, PA | adam.dicker@jefferson.edu | +1 215 955 8619 |
Built from public federal registries and the company's own website, counts banded deliberately.
If a walk-through is useful, pick a time at cal.com/ecg.
Prepared by Ben Beattie, ben@enquirerconsulting.com.